Venlafaxine Hydrochloride — Class III drug recall D-1167-2014
Terminated recall by McKesson Packaging Services, reported 2014-03-26, distributed nationwide. Failed Dissolution Specification: Out of Specification dissolution results at 12 month interval.
| Recall number | D-1167-2014 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | McKesson Packaging Services, Concord, NC, United States |
| Recall initiated | 2014-03-03 |
| Classified | 2014-03-18 |
| Reported by FDA | 2014-03-26 |
| Terminated | 2014-08-14 |
| Distributed | Nationwide (US) |
| Quantity | 1,557 boxes |
| Reason classes | specification failure |
| NDC | 63739-0512-10 |
| Lot numbers | 91357 |
Product
Venlafaxine Hydrochloride, Extended Release Capsules, 150 mg, UD-100 Tablets per Box (10 x 10), Rx Only, Manufactured by: Teva Pharmaceuticals USA, 1090 Horsham Rd, North Wales, PA 19454, NDC 63739-0512-10
Reason for recall
Failed Dissolution Specification: Out of Specification dissolution results at 12 month interval.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1167-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.